Intravesical Bacillus Calmette-Guerin for non-muscle invasive urothelial carcinoma of the bladder - patterns of use, and impact on outcomes

被引：0
|
作者：
Azer, S. [1 ]
Ranasinghe, W. [3 ]
Gibson, L. [1 ]
Webb, C. [1 ]
Lioufas, P. A. [3 ]
Cetti, R. [3 ]
Frydenberg, M. [2 ,4 ]
Bolton, D. [1 ,2 ]
Appu, S. [2 ,4 ]
Sengupta, S. [2 ]
机构：
[1] Austin Hlth, Dept Urol, Melbourne, Vic, Australia
[2] Univ Melbourne, Austin Dept Surg, Melbourne, Vic 3010, Australia
[3] Monash Med Ctr, Dept Urol, Melbourne, Vic, Australia
[4] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia
来源：
BJU INTERNATIONAL | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
7
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] IDENTIFYING POLYMORPHISMS THAT MODULATE RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CARCINOMA
    Wang, Ziting
    Sng, Jen-Hwei
    Lim, Yew Koon
    Kesavan, Esuvaranathan
    Mahendran, Ratha
    Mani, Lata Raman Nee
    Chan, Yiong Huak
    Yeoh, Jeremy Yuen Chun
    Ng, Chi Fai
    Chan, Shu Yin Eddie
    Chiong, Edmund
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1234
  • [32] Identifying polymorphisms that modulate response to Bacillus Calmette-Guerin therapy in patients with non-muscle invasive bladder carcinoma
    Wang, Z.
    [J]. BJU INTERNATIONAL, 2018, 122 : 49 - 50
  • [33] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
  • [34] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
    Andrade, Danilo Leite
    Moretti, Tomas Bernardo Costa
    Neto, Wilmar Azal
    Benedetti, Julia
    Reis, Leonardo Oliveira
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
  • [35] CLINICAL SIGNIFICANCE OF THE CLASSIFICATION FOR BACILLUS CALMETTE-GUERIN FAILURE IN NON-MUSCLE INVASIVE BLADDER CANCERS
    Chamie, Karim
    Litwin, Mark S.
    Bassett, Jeffrey C.
    Daskivich, Timothy J.
    Lai, Julie
    Hanley, Jan M.
    Konety, Badrinath R.
    Saigal, Christopher S.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E713 - E714
  • [36] Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer.
    Alanee, Shaheen
    Hamilton, Robert James
    Joseph, Vijai
    Ostrovnaya, Irina
    Garcia-Grossman, Ilana Rebecca
    Gallagher, David J.
    Pendse, Deepa
    Regazzi, Ashley Marie
    Przybylo, Jennifer A.
    Gaudet, Mia
    Milowsky, Matthew I.
    Herr, Harry W.
    Offit, Kenneth
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    [J]. DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
  • [38] Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage
    Chun, Brian
    He, Meiqi
    Jones, Cameron
    Vasan, Robin
    Gabriel, Nico
    Jacobs, Bruce L.
    Hernandez, Inmaculada
    Davies, Benjamin J.
    [J]. UROLOGY, 2023, 177 : 74 - 80
  • [39] Pyuria as a Predictive Marker of Bacillus Calmette-Guerin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
    Suh, Jungyo
    Yuk, Hyeong Dong
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [40] CARCINOGENESIS AND BACILLUS CALMETTE-GUERIN (BCG) INTRAVESICAL TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER UNDER TRYPTOPHAN AND THYMINE SUPPLEMENTATION
    Ossick, Marina
    Kiehl, Isis
    Salustiano, Ana Clara
    Ferrari, Karen
    Degasperi, Giovanna
    Linarelli, Maria
    Reis, Leonardo
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E1133 - E1133
12345